5545-0013 Screening compound: 4-(2H-1,3-benzodioxol-5-yl)-1-(butan-2-yl)-3-hydroxy-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-7-one

5545-0013 Screening compound: 4-(2H-1,3-benzodioxol-5-yl)-1-(butan-2-yl)-3-hydroxy-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-7-one
5545-0013 Screening compound: 4-(2H-1,3-benzodioxol-5-yl)-1-(butan-2-yl)-3-hydroxy-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-7-one alternative view

Chemical Structure Depiction of ChemDiv screening compound 5545-0013
4-(2H-1,3-benzodioxol-5-yl)-1-(butan-2-yl)-3-hydroxy-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-7-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

5545-0013

Molecular Formula

C17H19N3O4S (C17 H19 N3 O4 S)

Compound Name

4-(2H-1,3-benzodioxol-5-yl)-1-(butan-2-yl)-3-hydroxy-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-7-one

IUPAC name

4-(2H-13-benzodioxol-5-yl)-1-(butan-2-yl)-3-hydroxy-1H4H6H7H8H-pyrazolo[34-e][14]thiazepin-7-one

SMILES

CCC(C)n(c(N1)c2C(c(cc3)cc4c3OCO4)SCC1=O)nc2O

InChI

InChI=1S/C17H19N3O4S/c1-3-9(2)20-16-14(17(22)19-20)15(25-7-13(21)18-16)10-4-5-11-12(6-10)24-8-23-11/h4-6,9,15H,3,7-8H2,1-2H3,(H,18,21)(H,19,22)

InChI Key

UEXRYUAOMLOVSX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03667961

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

361.42

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.726

Distribution Coefficient, logD

2.083

Water Solubility, LogSw

-3.12

Polar Surface Area

73.109

Acid Dissociation Constant (pKa)

6.87

Base Dissociation Constant (pKb)

-1.42

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

41.20

5545-0013 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

BRD4 Targeted Library (4534 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Hemic and lymphatic
  • Cardiovascular
  • Metabolic
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 5545-0013 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 5545-0013?
Check Price and Availability of 5545-0013, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 5545-0013 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 5545-0013
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 5545-0013
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 5545-0013 available by request